166 related articles for article (PubMed ID: 21325505)
41. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Tanaka T; Murakami K; Bando Y; Yoshida S
J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
[TBL] [Abstract][Full Text] [Related]
42. Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
Thiessen JD; Zhang Y; Zhang H; Wang L; Buist R; Del Bigio MR; Kong J; Li XM; Martin M
NMR Biomed; 2013 Nov; 26(11):1562-81. PubMed ID: 23943390
[TBL] [Abstract][Full Text] [Related]
43. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Tomas-Roig J; Wirths O; Salinas-Riester G; Havemann-Reinecke U
CNS Neurosci Ther; 2016 May; 22(5):387-95. PubMed ID: 26842941
[TBL] [Abstract][Full Text] [Related]
44. Deletion of Voltage-Gated Calcium Channels in Astrocytes during Demyelination Reduces Brain Inflammation and Promotes Myelin Regeneration in Mice.
Zamora NN; Cheli VT; Santiago González DA; Wan R; Paez PM
J Neurosci; 2020 Apr; 40(17):3332-3347. PubMed ID: 32169969
[TBL] [Abstract][Full Text] [Related]
45. Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination.
Zhang S; Zhu X; Gui X; Croteau C; Song L; Xu J; Wang A; Bannerman P; Guo F
J Neurosci; 2018 Feb; 38(7):1802-1820. PubMed ID: 29335358
[TBL] [Abstract][Full Text] [Related]
46. Temporal Changes in In Vivo Glutamate Signal during Demyelination and Remyelination in the Corpus Callosum: A Glutamate-Weighted Chemical Exchange Saturation Transfer Imaging Study.
Lee DW; Heo H; Woo CW; Woo DC; Kim JK; Kim KW; Lee DH
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322784
[TBL] [Abstract][Full Text] [Related]
47. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
Clarner T; Diederichs F; Berger K; Denecke B; Gan L; van der Valk P; Beyer C; Amor S; Kipp M
Glia; 2012 Oct; 60(10):1468-80. PubMed ID: 22689449
[TBL] [Abstract][Full Text] [Related]
48. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
Selvaraju R; Bernasconi L; Losberger C; Graber P; Kadi L; Avellana-Adalid V; Picard-Riera N; Baron Van Evercooren A; Cirillo R; Kosco-Vilbois M; Feger G; Papoian R; Boschert U
Mol Cell Neurosci; 2004 Apr; 25(4):707-21. PubMed ID: 15080898
[TBL] [Abstract][Full Text] [Related]
49. Postnatal Sonic hedgehog (Shh) responsive cells give rise to oligodendrocyte lineage cells during myelination and in adulthood contribute to remyelination.
Sanchez MA; Armstrong RC
Exp Neurol; 2018 Jan; 299(Pt A):122-136. PubMed ID: 29045809
[TBL] [Abstract][Full Text] [Related]
50. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination.
Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y
Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175
[TBL] [Abstract][Full Text] [Related]
51. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M
Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876
[TBL] [Abstract][Full Text] [Related]
52. Detection of myelination using a novel histological probe.
Xiang Z; Nesterov EE; Skoch J; Lin T; Hyman BT; Swager TM; Bacskai BJ; Reeves SA
J Histochem Cytochem; 2005 Dec; 53(12):1511-6. PubMed ID: 16046669
[TBL] [Abstract][Full Text] [Related]
53. K+ channel blockade impairs remyelination in the cuprizone model.
Bacia A; Wollmann R; Soliven B
Glia; 2004 Nov; 48(2):156-65. PubMed ID: 15378653
[TBL] [Abstract][Full Text] [Related]
54. Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.
Clarner T; Parabucki A; Beyer C; Kipp M
J Neuroendocrinol; 2011 Jul; 23(7):601-11. PubMed ID: 21507085
[TBL] [Abstract][Full Text] [Related]
55. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
56. Dcf1 deficiency induces hypomyelination by activating Wnt signaling.
Feng R; Wang J; Luo G; Wang H; Shi J; TieqiaoWen
Exp Neurol; 2021 Jan; 335():113486. PubMed ID: 32991932
[TBL] [Abstract][Full Text] [Related]
57. Reversing hypomyelination in BACE1-null mice with Akt-DD overexpression.
Hu X; Schlanger R; He W; Macklin WB; Yan R
FASEB J; 2013 May; 27(5):1868-73. PubMed ID: 23335052
[TBL] [Abstract][Full Text] [Related]
58. Dominant-negative beta1 integrin mice have region-specific myelin defects accompanied by alterations in MAPK activity.
Lee KK; de Repentigny Y; Saulnier R; Rippstein P; Macklin WB; Kothary R
Glia; 2006 Jun; 53(8):836-44. PubMed ID: 16575886
[TBL] [Abstract][Full Text] [Related]
59. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
[TBL] [Abstract][Full Text] [Related]
60. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair.
Marriott MP; Emery B; Cate HS; Binder MD; Kemper D; Wu Q; Kolbe S; Gordon IR; Wang H; Egan G; Murray S; Butzkueven H; Kilpatrick TJ
Glia; 2008 Apr; 56(6):686-98. PubMed ID: 18293407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
